<?xml version="1.0" encoding="UTF-8"?>
<p id="p0410">There are two types of vaccination available in the United Kingdom, the oral live-attenuated vaccine and the polysaccharide vaccine. The oral live-attenuated vaccine should be avoided in patients on biological therapies. The polysaccharide vaccine is safe to use in immunosuppressed patients and should be given intramuscularly [
 <xref rid="bib22" ref-type="bibr">22</xref>]. Studies in immunocompetent individuals estimate the efficacy of the vaccine to be between 55% and 75%; efficacy in immunosuppressed patients is likely to be lower. There are no specific data on the immune response generated by typhoid vaccination in patients on biological therapy [
 <xref rid="bib25" ref-type="bibr">25</xref>]. Due to the uncertainty around vaccine response patients should be advised of the importance of following food and water hygiene measures where possible. There is no effective vaccination against paratyphoid.
</p>
